Company intelligence / Profile preview
Infensa Bioscience
Brisbane, Queensland, Australiainfensabioscience.com ↗
- Ownership
- Private
- Employees
- ~13
- Development stage
- Other
01
Overview
Infensa Bioscience develops first-in-class peptide therapeutics derived from Australian funnel web spider venom. Their lead candidate, Hi1a, inhibits ASIC1a channels to protect heart and brain cells from ischemic damage during heart attacks or strokes. Preclinical studies show Hi1a can selectively protect injured tissue without affecting healthy cells. The company has raised significant funding to advance into human clinical trials targeting acute cardiovascular events where no current drugs exist to prevent organ damage.
- Therapeutic areas
- Cardiovascular
- Modalities
- Peptides (notably venom-derived peptides)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Brisbane Economic Development Agency’s MedTech Global Accelerator program supports the company with access to partnerships and capitalcollaborations with University of Queensland researchers.
Beyond the preview
Go deeper on Infensa Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Infensa Bioscience.